The Eastern Virginia Medical School (EVMS) Biomarkers Developmental Laboratory (a member of the Early Detection Research Network or EDRN) is an integrated multidisciplinary program where investigators use mass spectrometry technology to mine the proteome for unique cancer biomarkers and protein expression fingerprints that can be used to improve the early detection of prostate, breast and head and neck cancers. As a member of the EDRN since its inception, EVMS has led significant efforts in the application of novel proteomic tools to examine the phenotypic traits of tumors and/or the tumor environment in search of protein biomarkers for the early detection and risk assessment of cancer. During the next five years, the EVMS team of investigators will continue to pursue the following aims independently and in collaboration with other network partners and industry-based scientists. The overall objectives will be met through three aims;1.) determine the clinical utility of protein profiling as a diagnostic test;2.) discover protein biomarkers for the early detection of cancer;and 3.) isolate and characterize protein biomarkers. In the first aim we will continue to develop SELDI profiling as a diagnostic tool for prostate and Head &Neck cancers. We also describe our studies to significantly improve this platform through improved peak picking and data analysis methods and we describe a novel proteomic tool, ClinProt UltraFlex (MALDI-TOF/TOF) for biomarker discovery. In the second aim we will examine body fluids and tissue for early markers of breast, prostate and H&N cancer. In the third aim we describe our approach to sequence identification and characterization of candidate biomarkers for early detection and risk assessment. Our unique team of investigators from basic sciences, mathematical sciences and the clinical arena supply the needed expertise to continue our work in biomarker development.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01CA085067-10S1
Application #
7911249
Study Section
Special Emphasis Panel (ZCA1-SRRB-E (O1))
Program Officer
Kagan, Jacob
Project Start
1999-09-30
Project End
2010-06-30
Budget Start
2008-08-01
Budget End
2010-06-30
Support Year
10
Fiscal Year
2009
Total Cost
$409,141
Indirect Cost
Name
Eastern Virginia Medical School
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
058625146
City
Norfolk
State
VA
Country
United States
Zip Code
23501
Kim, Yunee; Jeon, Jouhyun; Mejia, Salvador et al. (2016) Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer. Nat Commun 7:11906
Moul, Judd W; Lilja, Hans; Semmes, O John et al. (2012) NADiA ProsVue prostate-specific antigen slope is an independent prognostic marker for identifying men at reduced risk of clinical recurrence of prostate cancer after radical prostatectomy. Urology 80:1319-25
Principe, Simona; Kim, Yunee; Fontana, Simona et al. (2012) Identification of prostate-enriched proteins by in-depth proteomic analyses of expressed prostatic secretions in urine. J Proteome Res 11:2386-96
Laskin, Julia; Heath, Brandi S; Roach, Patrick J et al. (2012) Tissue imaging using nanospray desorption electrospray ionization mass spectrometry. Anal Chem 84:141-8
Kim, Yunee; Ignatchenko, Vladimir; Yao, Cindy Q et al. (2012) Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer. Mol Cell Proteomics 11:1870-84
Cazares, Lisa H; Troyer, Dean A; Wang, Binghe et al. (2011) MALDI tissue imaging: from biomarker discovery to clinical applications. Anal Bioanal Chem 401:17-27
Green-Mitchell, Shamina M; Cazares, Lisa H; Semmes, O John et al. (2011) On-tissue identification of insulin: in situ reduction coupled with mass spectrometry imaging. Proteomics Clin Appl 5:448-53
Yang, Lifang; Nyalwidhe, Julius O; Guo, Siqi et al. (2011) Targeted identification of metastasis-associated cell-surface sialoglycoproteins in prostate cancer. Mol Cell Proteomics 10:M110.007294
Drake, Richard R; Cazares, Lisa H; Jones, E Ellen et al. (2011) Challenges to developing proteomic-based breast cancer diagnostics. OMICS 15:251-9
Dai, Chaofeng; Cazares, Lisa H; Wang, Lifang et al. (2011) Using boronolectin in MALDI-MS imaging for the histological analysis of cancer tissue expressing the sialyl Lewis X antigen. Chem Commun (Camb) 47:10338-40

Showing the most recent 10 out of 43 publications